Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-24 @ 7:44 PM
NCT ID:
NCT01128803
Eligibility Criteria:
Pre-inclusion Criteria :
* Adults (men or women) aged between 18 and 80 years
* Patients affiliated to a social security reimbursement system
* Signed informed consent
* Hepatocellular carcinoma
* At least one dosage with Alpha-foeto-protein ≥ 40 ng/ml
* Patient already treated with chemoembolization, percutaneous destruction (alcohol or radiofrequency), surgery or Sorafenib.
Inclusion Criteria:
* Negative test for pregnancy or effective contraception
* Patient HIV-, Hep B-, Hep C-, HTLV1 and 2-, Syphilis-
* HLA A 0201 group
Exclusion Criteria:
* Life expectancy \< 3 months
* Pregnancy or breast-feeding
* Severe auto-immune disease
* Another malignant tumor except if considered as cured since more than 5 years
* History of uncontrolled psychiatric condition
* Risk factors of Creutzfeldt Jacobs disease
* Decompensated cirrhosis(ascites or Child-Pugh score greater than 8)
* Hepatic transplantation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01128803
Study Brief:
Protocol Section:
NCT01128803